Penumbra IncPEN

時価総額

$111.7億

PER

血栓除去用医療機器の最大手。CAVTなどの血栓除去・塞栓・アクセス用デバイスを展開。2024年売上は1,194.6百万ドル、同年に没入型事業撤退で115.3百万ドルの減損計上。米国・欧州・カナダ・オーストラリア中心に展開。

	2015年 12月31日	2016年 12月31日	2017年 12月31日	2018年 12月31日	2019年 12月31日	2020年 12月31日	2021年 12月31日	2022年 12月31日	2023年 12月31日	2024年 12月31日
Net income (loss)	-	-	5	3	47	-19	3	-2	91	14
Depreciation and amortization	2	2	4	6	8	13	16	24	27	24
Stock-based compensation	7	15	18	18	21	26	66	37	51	46
Impairment charge	-	-	-	-	-	-	-	-	-	77
Inventory Write-down	1	3	1	2	4	11	3	3	6	44
Deferred taxes	-3	-12	-4	-6	2	-19	-14	1	-19	-16
Acquired in-process research and development	-	-	-	-	-	-	-	-	18	-
Other	-	-	1	0	0	5	3	1	2	4
Accounts receivable	11	15	9	26	25	8	21	70	0	-27
Inventories	25	20	19	22	41	57	52	75	68	66
Prepaid expenses and other current and non-current assets	4	9	-2	-2	4	9	13	1	19	3
Accounts payable	0	1	2	1	6	-0	-2	13	1	4
Accrued expenses and other non-current liabilities	8	6	10	14	8	23	17	11	6	14
Proceeds from lease incentives	-	-	-	-	-	-	4	0	0	-
Net cash provided by (used in) operating activities	-22	-13	13	29	27	-33	10	-56	97	168
Asset acquisition, net of cash acquired	-	-	-	-	-	-	-	-	1	-
Purchases of non-marketable investments	-	-	5	1	-	-	-	-	-	10
Purchases of marketable investments	-	-	-	-	-	-	127	-	82	23
Proceeds from sales of marketable investments	-	-	-	-	-	-	2	1	-	-
Proceeds from maturities of marketable investments	-	65	113	127	91	69	122	73	83	131
Purchases of property and equipment	5	14	13	10	22	25	21	19	15	21
Other	-	-	-	-	2	3	0	-	1	-1
Net cash provided by (used in) investing activities	-86	1	-78	-0	-13	-104	-22	55	-16	78
Proceeds from Stock Options Exercised	1	3	5	5	4	5	5	8	6	2
Proceeds from Stock Plans	-	7	6	7	9	11	14	14	15	15
Payment of employee taxes related to vested common and restricted stock	3	3	12	18	19	10	16	8	2	1
Payments of finance lease obligations	-	-	-	-	3	3	1	2	2	2
Repurchase of common stock	-	-	-	-	-	-	-	-	-	100
Other	-	-	-	-	-	-2	-0	-0	-0	-0
Net cash (used in) provided by financing activities	124	7	104	-10	-9	135	1	12	16	-87
Effect of foreign exchange rate changes on cash and cash equivalents	-	-	-	-	-0	-1	1	-0	0	-2
NET INCREASE IN CASH AND CASH EQUIVALENTS	-	-	-	-	5	-3	-10	10	98	157
Income Taxes Paid	1	2	0	0	0	1	1	3	7	21
Right-of-Use Asset Obtained in Exchange for Operating Lease Liability	-	-	-	-	-	-	102	72	9	2
Right-of-Use Asset Obtained in Exchange for Finance Lease Liability	-	-	-	-	-	-	1	0	1	0
Shares	-	-	-	-	-	-	174	-	17	-
Stock Options	-	-	-	-	-	-	81	-	-	-
Capital Expenditures Incurred but Not yet Paid	0	1	1	1	3	1	2	2	1	2
Share Repurchase Program, Excise Tax	-	-	-	-	-	-	-	-	-	0